R. Langley
Oncology · with Fidler · 2011
A researcher in the Science corpus: 1 paper; trusts 3 researchers and is trusted by 2 researchers here, as inferred from the citation graph.
Subfields
- Oncology — 14 citations into it; #810 of 1,698 by trust here, #1,501 by citations
- Molecular Biology — 11 citations into it
- Cancer Research — 8 citations into it
Whom R. Langley trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts R. Langley overall
Papers from R. Langley's perspective
Ordered by how strongly the researchers R. Langley trusts endorse each paper. Same corpus, a different order for every researcher.
- Vascular endothelial growth factor: basic science and clinical progress. (Endocrine reviews)
- Involvement of chemokine receptors in breast cancer metastasis (Nature)
- Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer. (New England Journal of Medicine)
- Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. (New England Journal of Medicine)
- Intravascular origin of metastasis from the proliferation of endothelium-attached tumor cells: a new model for metastasis (Nature Medicine)
- Distant Metastasis Occurs Late during the Genetic Evolution of Pancreatic Cancer (Nature)
- The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited (Nature Reviews. Cancer)
- Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer. (New England Journal of Medicine)
- Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma (Nature Medicine)
- Heterogeneity of angiogenesis and blood vessel maturation in human tumors: implications for antiangiogenic tumor therapies. (Cancer Research)